Trials in New York, New York
Here are the top 10 medical studies for prostate cancer in New York, New York
Popular Filters
Phase 3 Trials
Radiation
Darolutamide + Standard Therapy for Prostate Cancer
Recruiting1 awardPhase 3
Toronto, Ontario
This trial is testing darolutamide, a new drug added to standard hormone therapy, in men with high-risk localized prostate cancer undergoing radiation. The goal is to see if this combination can better prevent the cancer from coming back and spreading compared to current treatments. Darolutamide works by blocking male hormones that help cancer grow, potentially reducing death rates from prostate cancer.
Diagnostic Test
PSMA PET/CT for Advanced Prostate Cancer
Recruiting2 awardsPhase 3
Hamilton, Ontario
This trial is testing if a special imaging scan can help doctors give better-targeted and stronger treatments for high-risk prostate cancer patients. The scan highlights cancer cells, guiding more precise treatments. The goal is to improve patient outcomes and quality of life. This new imaging method has revolutionized prostate cancer detection, making it a promising tool for evaluating patients.
Androgen Receptor Antagonist
Hormone + Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Buffalo, New York
This trial is testing two different intensities of hormone therapy and radiation therapy, comparing them to the current standard of care, in order to determine the best treatment plan for patients with high risk prostate cancer.
Trials With No Placebo
Androgen Receptor Inhibitor
Darolutamide + SBRT for Prostate Cancer
Recruiting2 awardsPhase 2
Hamilton, Ontario
This trial tests a combination of precise radiation therapy and a hormone-blocking drug in prostate cancer patients with limited spread. It aims to control the disease and delay more toxic treatments. The approach targets small areas of cancer spread and blocks the cancer's growth signals. The hormone-blocking drug is a novel treatment approved for specific prostate cancer cases.
Anti-mitotic Agent
ctDNA-Guided Therapy for Prostate Cancer
Recruiting1 awardPhase 2
Toronto, British Columbia
This trial tests if using a blood marker to choose between two treatments is better than doctors choosing the treatment for advanced prostate cancer patients who did not respond to previous therapy.
Procedure
Nutrition and Exercise Advice for Prostate Cancer
Recruiting1 award10 criteria
Buffalo, New York
This trial looks at whether giving nutrition and exercise advice to prostate cancer patients who are on androgen deprivation therapy can help to reduce obese frailty and change the levels of myokines in blood.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.